2 days Nurix Therapeutics (NASDAQ:NRIX) Price Target Lowered to $26.00 at Royal Bank of CanadaMarketBeat
Royal Bank of Canada lowered their price target on shares of Nurix Therapeutics from $27.00 to $26.00 and set an “outperform” rating on the stock in a report on Monday.
Canada · Nasdaq 100 · Royal Bank of Canada
X